BLND - Hot Stocks: Chinese stocks rise; SAGE clinical data; TELL upgrade; BB BLND plunge on results

Wall Street ended a two-day losing streak on Friday, as a late-day push allowed the major U.S. equity indices to finish a choppy session with gains. Amid a solid jobs report and an inverted yield curve, investors considered whether the rally that marked most of late March could resume in the near future. While uncertainty marked most of Friday's action, Chinese stocks were able to post unambiguous gains. The advance came on reports that Beijing authorities would approve more transparency for companies listed on U.S. markets. On the news, DiDi Global (DIDI), KE Holdings (BEKE), Bilibili (BILI), Pinduoduo (PDD), JD.com (JD) and Alibaba (BABA) all finished higher. Elsewhere, Sage Therapeutics (SAGE) represented another notable gainer on the session. Strong clinical trial data for an Alzheimer’s drug triggered a double-digit percentage gain in the stock. Meanwhile, Tellurian (TELL) soared to a new 52-week high following an analyst's upgrade. Looking at some

For further details see:

Hot Stocks: Chinese stocks rise; SAGE clinical data; TELL upgrade; BB, BLND plunge on results